Summit Securities Group’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-320
Closed -$1K 623
2024
Q3
$1K Buy
+320
New +$1K ﹤0.01% 392